[Hyperlipoproteinemia in children]

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Cardiovascular Health in Children

Background:

• Hyperlipoproteinemia (HLP) is a prevalent metabolic disorder in childhood, impacting lipid metabolism.
• Prevalence is estimated at 20% in children, with varying severity from moderate to severe forms.
• HLP can be secondary to other conditions or primary, stemming from monogenic or polygenic disorders.

Purpose of the Study:

• To outline the diagnostic approaches for hyperlipoproteinemia in children.
• To describe current treatment strategies for pediatric hyperlipoproteinemia.
• To highlight the significance of early detection and intervention for lipid metabolism disorders in youth.

Main Methods:

• Detection through random screening and selective screening of children with a family history of cardiovascular disease.
• Assessment by general pediatric practitioners for children and adolescents.
• Utilizing diagnostic criteria for hyperlipoproteinemia in pediatric populations.

Main Results:

• HLP is a common condition in childhood, with a significant percentage of children affected by lipid metabolism disorders.
• Screening methods identify children with HLP, often those with a familial predisposition to cardiovascular issues.
• Treatment approaches vary based on HLP type and severity, with diet being primary and pharmacotherapy used in specific cases.

Conclusions:

• Early diagnosis of hyperlipoproteinemia in children is essential for timely management.
• Dietary interventions are the cornerstone of treatment, supplemented by pharmacotherapy for severe cases like familial hypercholesterolemia.
• Pediatricians play a vital role in identifying and managing childhood hyperlipoproteinemia to prevent long-term cardiovascular complications.